Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage

Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain un...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cutaneous medicine and surgery 2022-11, Vol.26 (6), p.600-603
Hauptverfasser: Chang, Jasmine, Litvinov, Ivan V., Ly, Christina, Netchiporouk, Elena, Tsoukas, Alexander, Thuraisingam, Thusanth, Starr, Michael, Powell, Mathieu, Christodoulou, George, Shamout, Yassein
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 603
container_issue 6
container_start_page 600
container_title Journal of cutaneous medicine and surgery
container_volume 26
creator Chang, Jasmine
Litvinov, Ivan V.
Ly, Christina
Netchiporouk, Elena
Tsoukas, Alexander
Thuraisingam, Thusanth
Starr, Michael
Powell, Mathieu
Christodoulou, George
Shamout, Yassein
description Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm.
doi_str_mv 10.1177/12034754221128796
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9729972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_12034754221128796</sage_id><sourcerecordid>2747221065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</originalsourceid><addsrcrecordid>eNp1kktv1DAQxyMEoqXwAbggS1zKIcV2_Eg4VFqVFIqKWHW358jJTnanJPFie1fafrp-NLyklJc4WPZofvOfhydJXjJ6wpjWbxmnmdBScM4Yz3WhHiWHTDGZakaLx_Ed_ekeOEieeX9DKWVMiqfJQaY4E1mmD5O764Ad3pqAdiC2JWEFZOqtQ-PRk3KNC-jRdna5I7PGAQw4LMnc2o4cT8vZ_M07MiFX6L-SWXBRpMVmlPphQoxqrSOlcd2OXEELzplun2ZMEbAhExdWDkNMNo02DMGTYMlnHLDHWyAXzsEWnMe6A1I663EL5JPFIZD3pjdLeJ48aU3n4cX9fZRcn5fzs4_p5ZcPF2eTy7QRSoWU81oIIWUueFGLBrha5Dmvc90YWSjBclZoQw1VWigOEnTOZb4ApanUtTQsO0pOR931pu5h0cRKYy_V2mFv3K6yBqs_PQOuqqXdVoXmRTxR4PhewNlvG_Ch6tE30HVmALvxFY-MyDMm84i-_gu9sRs3xPYiJXT8bqpkpNhINXEs3kH7UAyj1X4_qn_2I8a8-r2Lh4ifCxGBkxHwcba_0v5f8TsSB8UG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2747221065</pqid></control><display><type>article</type><title>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Chang, Jasmine ; Litvinov, Ivan V. ; Ly, Christina ; Netchiporouk, Elena ; Tsoukas, Alexander ; Thuraisingam, Thusanth ; Starr, Michael ; Powell, Mathieu ; Christodoulou, George ; Shamout, Yassein</creator><creatorcontrib>Chang, Jasmine ; Litvinov, Ivan V. ; Ly, Christina ; Netchiporouk, Elena ; Tsoukas, Alexander ; Thuraisingam, Thusanth ; Starr, Michael ; Powell, Mathieu ; Christodoulou, George ; Shamout, Yassein</creatorcontrib><description>Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm.</description><identifier>ISSN: 1203-4754</identifier><identifier>EISSN: 1615-7109</identifier><identifier>DOI: 10.1177/12034754221128796</identifier><identifier>PMID: 36214337</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Arthritis, Psoriatic - diagnosis ; Arthritis, Psoriatic - drug therapy ; Arthritis, Psoriatic - epidemiology ; Humans ; Medical screening ; Original ; Prospective Studies ; Psoriasis ; Psoriasis - complications ; Psoriasis - drug therapy ; Psoriasis - epidemiology ; Psoriatic arthritis ; Referral and Consultation ; Rheumatology ; Risk Assessment</subject><ispartof>Journal of cutaneous medicine and surgery, 2022-11, Vol.26 (6), p.600-603</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022 2022 Canadian Dermatology Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</citedby><cites>FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</cites><orcidid>0000-0003-0562-4675 ; 0000-0001-8414-6354 ; 0000-0001-5063-8991 ; 0000-0002-6692-7787</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/12034754221128796$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/12034754221128796$$EHTML$$P50$$Gsage$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,21800,27905,27906,43602,43603</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36214337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Jasmine</creatorcontrib><creatorcontrib>Litvinov, Ivan V.</creatorcontrib><creatorcontrib>Ly, Christina</creatorcontrib><creatorcontrib>Netchiporouk, Elena</creatorcontrib><creatorcontrib>Tsoukas, Alexander</creatorcontrib><creatorcontrib>Thuraisingam, Thusanth</creatorcontrib><creatorcontrib>Starr, Michael</creatorcontrib><creatorcontrib>Powell, Mathieu</creatorcontrib><creatorcontrib>Christodoulou, George</creatorcontrib><creatorcontrib>Shamout, Yassein</creatorcontrib><title>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</title><title>Journal of cutaneous medicine and surgery</title><addtitle>J Cutan Med Surg</addtitle><description>Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm.</description><subject>Arthritis, Psoriatic - diagnosis</subject><subject>Arthritis, Psoriatic - drug therapy</subject><subject>Arthritis, Psoriatic - epidemiology</subject><subject>Humans</subject><subject>Medical screening</subject><subject>Original</subject><subject>Prospective Studies</subject><subject>Psoriasis</subject><subject>Psoriasis - complications</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - epidemiology</subject><subject>Psoriatic arthritis</subject><subject>Referral and Consultation</subject><subject>Rheumatology</subject><subject>Risk Assessment</subject><issn>1203-4754</issn><issn>1615-7109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>EIF</sourceid><recordid>eNp1kktv1DAQxyMEoqXwAbggS1zKIcV2_Eg4VFqVFIqKWHW358jJTnanJPFie1fafrp-NLyklJc4WPZofvOfhydJXjJ6wpjWbxmnmdBScM4Yz3WhHiWHTDGZakaLx_Ed_ekeOEieeX9DKWVMiqfJQaY4E1mmD5O764Ad3pqAdiC2JWEFZOqtQ-PRk3KNC-jRdna5I7PGAQw4LMnc2o4cT8vZ_M07MiFX6L-SWXBRpMVmlPphQoxqrSOlcd2OXEELzplun2ZMEbAhExdWDkNMNo02DMGTYMlnHLDHWyAXzsEWnMe6A1I663EL5JPFIZD3pjdLeJ48aU3n4cX9fZRcn5fzs4_p5ZcPF2eTy7QRSoWU81oIIWUueFGLBrha5Dmvc90YWSjBclZoQw1VWigOEnTOZb4ApanUtTQsO0pOR931pu5h0cRKYy_V2mFv3K6yBqs_PQOuqqXdVoXmRTxR4PhewNlvG_Ch6tE30HVmALvxFY-MyDMm84i-_gu9sRs3xPYiJXT8bqpkpNhINXEs3kH7UAyj1X4_qn_2I8a8-r2Lh4ifCxGBkxHwcba_0v5f8TsSB8UG</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Chang, Jasmine</creator><creator>Litvinov, Ivan V.</creator><creator>Ly, Christina</creator><creator>Netchiporouk, Elena</creator><creator>Tsoukas, Alexander</creator><creator>Thuraisingam, Thusanth</creator><creator>Starr, Michael</creator><creator>Powell, Mathieu</creator><creator>Christodoulou, George</creator><creator>Shamout, Yassein</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0562-4675</orcidid><orcidid>https://orcid.org/0000-0001-8414-6354</orcidid><orcidid>https://orcid.org/0000-0001-5063-8991</orcidid><orcidid>https://orcid.org/0000-0002-6692-7787</orcidid></search><sort><creationdate>20221101</creationdate><title>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</title><author>Chang, Jasmine ; Litvinov, Ivan V. ; Ly, Christina ; Netchiporouk, Elena ; Tsoukas, Alexander ; Thuraisingam, Thusanth ; Starr, Michael ; Powell, Mathieu ; Christodoulou, George ; Shamout, Yassein</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-22b444558429b4ce26d882b87ca596418197a0a067462e5e78258de67057b5a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Arthritis, Psoriatic - diagnosis</topic><topic>Arthritis, Psoriatic - drug therapy</topic><topic>Arthritis, Psoriatic - epidemiology</topic><topic>Humans</topic><topic>Medical screening</topic><topic>Original</topic><topic>Prospective Studies</topic><topic>Psoriasis</topic><topic>Psoriasis - complications</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - epidemiology</topic><topic>Psoriatic arthritis</topic><topic>Referral and Consultation</topic><topic>Rheumatology</topic><topic>Risk Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Jasmine</creatorcontrib><creatorcontrib>Litvinov, Ivan V.</creatorcontrib><creatorcontrib>Ly, Christina</creatorcontrib><creatorcontrib>Netchiporouk, Elena</creatorcontrib><creatorcontrib>Tsoukas, Alexander</creatorcontrib><creatorcontrib>Thuraisingam, Thusanth</creatorcontrib><creatorcontrib>Starr, Michael</creatorcontrib><creatorcontrib>Powell, Mathieu</creatorcontrib><creatorcontrib>Christodoulou, George</creatorcontrib><creatorcontrib>Shamout, Yassein</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cutaneous medicine and surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Jasmine</au><au>Litvinov, Ivan V.</au><au>Ly, Christina</au><au>Netchiporouk, Elena</au><au>Tsoukas, Alexander</au><au>Thuraisingam, Thusanth</au><au>Starr, Michael</au><au>Powell, Mathieu</au><au>Christodoulou, George</au><au>Shamout, Yassein</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage</atitle><jtitle>Journal of cutaneous medicine and surgery</jtitle><addtitle>J Cutan Med Surg</addtitle><date>2022-11-01</date><risdate>2022</risdate><volume>26</volume><issue>6</issue><spage>600</spage><epage>603</epage><pages>600-603</pages><issn>1203-4754</issn><eissn>1615-7109</eissn><abstract>Psoriatic arthritis (PsA) can affect a diverse range of anatomical sites and its heterogeneous presentation contributes to misdiagnosis and delayed treatment with conventional and biologic disease-modifying antirheumatic drugs (DMARDs). Up to 15% of psoriasis (PsO) patients affected by PsA remain undiagnosed. Early detection and referral to a rheumatologist are crucial to optimize care and minimize irreversible erosive joint damage. To improve the rheumatology referral process, the authors propose a risk stratification tool to identify and triage patients with possible psoriatic arthritis. With the aim of ultimately assisting in early treatment initiation, this risk stratification algorithm can be used in both dermatology and primary care clinics. It is based on the Psoriasis Epidemiology Screening Tool (PEST) combined with the ClASsification criteria for Psoriatic Arthritis (CASPAR). This article intends to provide a rationale for further prospective studies whose objective would be to validate this screening algorithm.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>36214337</pmid><doi>10.1177/12034754221128796</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-0562-4675</orcidid><orcidid>https://orcid.org/0000-0001-8414-6354</orcidid><orcidid>https://orcid.org/0000-0001-5063-8991</orcidid><orcidid>https://orcid.org/0000-0002-6692-7787</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1203-4754
ispartof Journal of cutaneous medicine and surgery, 2022-11, Vol.26 (6), p.600-603
issn 1203-4754
1615-7109
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9729972
source MEDLINE; SAGE Complete A-Z List
subjects Arthritis, Psoriatic - diagnosis
Arthritis, Psoriatic - drug therapy
Arthritis, Psoriatic - epidemiology
Humans
Medical screening
Original
Prospective Studies
Psoriasis
Psoriasis - complications
Psoriasis - drug therapy
Psoriasis - epidemiology
Psoriatic arthritis
Referral and Consultation
Rheumatology
Risk Assessment
title Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utilization%20of%20the%20Psoriasis%20Epidemiology%20Screening%20Tool%20(PEST):%20A%20Risk%20Stratification%20Strategy%20for%20Early%20Referral%20of%20Psoriatic%20Arthritis%20Patients%20to%20Minimize%20Irreversible%20Erosive%20Joint%20Damage&rft.jtitle=Journal%20of%20cutaneous%20medicine%20and%20surgery&rft.au=Chang,%20Jasmine&rft.date=2022-11-01&rft.volume=26&rft.issue=6&rft.spage=600&rft.epage=603&rft.pages=600-603&rft.issn=1203-4754&rft.eissn=1615-7109&rft_id=info:doi/10.1177/12034754221128796&rft_dat=%3Cproquest_pubme%3E2747221065%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2747221065&rft_id=info:pmid/36214337&rft_sage_id=10.1177_12034754221128796&rfr_iscdi=true